QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 33 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | -54.3% | 80,094 | 0.0% | 0.02% | -51.4% |
| Q2 2022 | $46,000 | -13.2% | 80,094 | 0.0% | 0.04% | +5.7% |
| Q1 2022 | $53,000 | -38.4% | 80,094 | 0.0% | 0.04% | -36.4% |
| Q4 2021 | $86,000 | -17.3% | 80,094 | 0.0% | 0.06% | -28.6% |
| Q3 2021 | $104,000 | -34.6% | 80,094 | 0.0% | 0.08% | -34.2% |
| Q2 2021 | $159,000 | -26.4% | 80,094 | 0.0% | 0.12% | -32.0% |
| Q1 2021 | $216,000 | – | 80,094 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 4,250,000 | $16,873,000 | 0.26% |
| Virtu Financial LLC | 29,887 | $119,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 29,998 | $119,000 | 0.00% |
| JANE STREET GROUP, LLC | 10,783 | $43,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 537 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| Archer Investment Corp | 160 | $635,000 | 0.00% |
| BlackRock Inc. | 578 | $2,000 | 0.00% |